Search results
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 7 days agoBiosimilars were available at lower prices than Humira through the three largest benefit managers, ...
We need to stop having 'emotional check-ins' at work
Business Insider· 4 days agoGen Zers grew up amid a movement to destigmatize mental illness and encourage people to get treatment. In a recent survey of US businesses conducted by...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges...
Benzinga· 6 days agoAbbVie Inc’s ABBV top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S. over the past year, Reuters reports ...
Atlanta's No.1 killer: The critical need to address heart health today - Atlanta Business Chronicle
The Business Journals· 4 days agoAcross metro Atlanta, individuals with cardiovascular disease frequently encounter barriers to...
Readout of White House Convening on Contraception Access on the 59th Anniversary of Griswold v....
The White House· 6 days agoToday, to mark the 59th anniversary of the Supreme Court’s landmark decision in Griswold v....
Guest Invitation to Momentum AI Summit in July
Digital Journal· 3 days agoDevelopment CVS Health EVP and Chief Digital, Data, Analytics and Technology Officer eBay CMO Eli Lilly Chief Information and Digital ...
Bill Gross Says Europe Is the Land of Bond Opportunity
Bloomberg· 3 days agoHave a confidential tip for our reporters? Bond king Bill Gross says Europe is the place to look for opportunity. “There’s coming a point where European bonds are more attractive than Treasury ...
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
The State· 15 hours agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients, independent pharmacists say they're struggling to afford to keep some prescription drugs in ...
AbbVie's tight grip on Humira market raises concerns about biosimilars
AOL· 7 days agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew of biosimilars, which are close but not exact copies of branded biologic medicines. But after ...
Biden Plan to Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say
North Denver News· 3 days agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients, independent pharmacists say they’re struggling to afford to keep some prescription drugs in ...